Activation of human α1 and α2 homomeric glycine receptors by taurine and GABA

1 Two ligand binding α subunits, α1 and α2, of the human (H) glycine receptor (GlyR) are involved at inhibitory synapses in the adult and neonatal spinal cord, respectively. The ability of homomeric αH1 and αH2 GlyRs to be activated by glycine, taurine and GABA was studied in Xenopus oocytes or in the human embryonic kidney HEK‐293 cell line. 2 In outside‐out patches from HEK cells, glycine, taurine and GABA activated both GlyRs with the same main unitary conductance, i.e. 85 ± 3 pS (n= 6) for αH1, and 95 ± 5 pS (n = 4) for αH2. 3 The sensitivity of both αH1 and αH2 GlyRs to glycine was highly variable. In Xenopus oocytes the EC50 for glycine (EC50gly) was between 25 and 280 μm for αH1 (n= 44) and between 46 and 541 μm for αH2 (n= 52). For both receptors, the highest EC50gly values were found on cells with low maximal glycine responses. 4 The actions of taurine and GABA were dependent on the EC50gly: (i) their EC50 values were linearly correlated to EC50gly, with EC50tau≈ 10 EC50gly and EC50GABA≈ 500‐800 EC50gly; (ii) they could act either as full or weak agonists depending on the EC50gly. 5 The Hill coefficient (nH) of glycine remained stable regardless of the EC50gly whereas nH for taurine decreased with increasing EC50tau. 6 The degree of desensitization, evaluated by fast application of saturating concentrations of agonist on outside‐out patches from Xenopus oocytes, was similar for glycine and taurine on both GlyRs and did not exceed 50 %. 7 Our data concerning the variations of EC50gly and the subsequent behaviour of taurine and GABA could be qualitatively described by the simple del Castillo‐Katz scheme, assuming that the agonist gating constant varies whereas the binding constants are stable. However, the stability of the Hill coefficient for glycine was not explained by this model, suggesting that other mechanisms are involved in the modulation of EC50.

[1]  P. Bregestovski,et al.  Isolation and characterization of an alpha 2-type zebrafish glycine receptor subunit , 2001, Neuroscience.

[2]  P. Bregestovski,et al.  Fast Potentiation of Glycine Receptor Channels by Intracellular Calcium in Neurons and Transfected Cells , 2000, Neuron.

[3]  P. Legendre,et al.  Development of spontaneous glycinergic currents in the Mauthner neuron of the zebrafish embryo. , 2000, Journal of neurophysiology.

[4]  H. Rohrer,et al.  Glycine receptors containing the α4 subunit in the embryonic sympathetic nervous system, spinal cord and male genital ridge , 2000, The European journal of neuroscience.

[5]  H. Betz,et al.  A novel domain of the inhibitory glycine receptor determining antagonist efficacies: further evidence for partial agonism resulting from self-inhibition. , 1999, Molecular pharmacology.

[6]  C. Grewer Investigation of the alpha(1)-glycine receptor channel-opening kinetics in the submillisecond time domain. , 1999, Biophysical journal.

[7]  P. Bregestovski,et al.  Comparison of glycine and GABA actions on the zebrafish homomeric glycine receptor , 1999, The Journal of physiology.

[8]  R. Harvey,et al.  Structure and Functions of Inhibitory and Excitatory Glycine Receptors , 1999, Annals of the New York Academy of Sciences.

[9]  Alastair M. Hosie,et al.  Actions of 3‐[2′‐phosphonomethyl[1,1′‐biphenyl]‐3‐yl]alanine (PMBA) on cloned glycine receptors , 1999, British journal of pharmacology.

[10]  P. Bregestovski,et al.  Cloning, expression and electrophysiological characterization of glycine receptor alpha subunit from zebrafish , 1999, Neuroscience.

[11]  M. Wick,et al.  Stable expression of human glycine α 1 and α 2 homomeric receptors in mouse L(tk−) cells , 1999, Journal of Neuroscience Methods.

[12]  P. Schofield,et al.  The startle disease mutation Q266H, in the second transmembrane domain of the human glycine receptor, impairs channel gating. , 1999, Molecular pharmacology.

[13]  D. Colquhoun,et al.  Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptors , 1998, British journal of pharmacology.

[14]  D. Bayliss,et al.  Development of glycinergic synaptic transmission to rat brain stem motoneurons. , 1998, Journal of neurophysiology.

[15]  R. Harris,et al.  Enhancement of glycine receptor function by ethanol: role of phosphorylation , 1998, British journal of pharmacology.

[16]  C. Becker,et al.  The inhibitory glycine receptor: prospects for a therapeutic orphan? , 1998, Current pharmaceutical design.

[17]  P. Legendre A Reluctant Gating Mode of Glycine Receptor Channels Determines the Time Course of Inhibitory Miniature Synaptic Events in Zebrafish Hindbrain Neurons , 1998, The Journal of Neuroscience.

[18]  T. Lewis,et al.  Properties of human glycine receptors containing the hyperekplexia mutation α1(K276E), expressed in Xenopus oocytes , 1998, The Journal of physiology.

[19]  J. Changeux,et al.  The multiple phenotypes of allosteric receptor mutants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Betz,et al.  Pharmacology of the inhibitory glycine receptor: agonist and antagonist actions of amino acids and piperidine carboxylic acid compounds. , 1995, Molecular pharmacology.

[21]  P. Schofield,et al.  Mutation of an arginine residue in the human glycine receptor transforms β-alanine and taurine from agonists into competitive antagonists , 1995, Neuron.

[22]  J. Bormann,et al.  Decreased agonist affinity and chloride conductance of mutant glycine receptors associated with human hereditary hyperekplexia. , 1994, The EMBO journal.

[23]  O. Taleb,et al.  Expression of the human glycine receptor alpha 1 subunit in Xenopus oocytes: apparent affinities of agonists increase at high receptor density. , 1994, The EMBO journal.

[24]  H. Betz,et al.  Mutation of glycine receptor subunit creates beta-alanine receptor responsive to GABA. , 1993, Science.

[25]  J. Bormann,et al.  Residues within transmembrane segment M2 determine chloride conductance of glycine receptor homo- and hetero-oligomers. , 1993, The EMBO journal.

[26]  A. Momiyama,et al.  Functional correlation of fetal and adult forms of glycine receptors with developmental changes in inhibitory synaptic receptor channels , 1992, Neuron.

[27]  H. Betz,et al.  Agonist pharmacology of neonatal and adult glycine receptor alpha subunits: identification of amino acid residues involved in taurine activation. , 1992, The EMBO journal.

[28]  R. Twyman,et al.  Kinetic properties of the glycine receptor main‐ and sub‐conductance states of mouse spinal cord neurones in culture. , 1991, The Journal of physiology.

[29]  T. Mohandas,et al.  Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes. , 1990, The EMBO journal.

[30]  Bernard Katz,et al.  Interaction at end-plate receptors between different choline derivatives , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[31]  A. Kriegstein,et al.  Nonsynaptic Glycine Receptor Activation during Early Neocortical Development , 1998, Neuron.

[32]  P. Schofield,et al.  Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channel , 1997, The EMBO journal.

[33]  P. Schofield,et al.  The glycine receptor. , 1997, Pharmacology & therapeutics.

[34]  P. Schofield,et al.  The human glycine receptor beta subunit: primary structure, functional characterisation and chromosomal localisation of the human and murine genes. , 1996, Brain research. Molecular brain research.

[35]  J. Bormann,et al.  The atypical M2 segment of the beta subunit confers picrotoxinin resistance to inhibitory glycine receptor channels. , 1994, The EMBO journal.

[36]  R. Werman Amino acids as central neurotransmitters. , 1972, Research publications - Association for Research in Nervous and Mental Disease.